Annual Reports and Accounts

Annual Report and Accounts
Mental Health Investment Standard Statement of Compliance 2023/2024
Nottingham and Nottinghamshire ICB Annual Report and Accounts April 2024-March 2025
Nottingham and Nottinghamshire ICB Annual Report and Accounts April 2023-March 2024
NHS England Annual Assessment 2024-2025
Nottingham and Nottinghamshire ICB Annual Report and Accounts July 2022-March 2023
Auditor’s Annual Report 2022/23
NHS England Annual Assessment of Nottingham and Nottinghamshire ICB 2022/23
Nottingham and Nottinghamshire LEDER Annual Report 2022/23
Nottingham and Nottinghamshire LEDER Annual Report 2022/23 – Easy Read
NHS Nottingham and Nottinghamshire CCG Annual Report and Accounts 2021/22
NHS Nottingham and Nottinghamshire CCG Auditors Report 2021/22
NHS Bassetlaw CCG Annual Report and Accounts 2021/22
NHS Bassetlaw CCG Auditors Report 2021/22
NHS Bassetlaw CCG Annual Report and Accounts April-June 2022
NHS Nottingham and Nottinghamshire CCG Annual and Accounts April-June 2022
22/23 Statements of Compliance for the Mental Health Investment Standard
All ICBs were required to plan to achieve the Mental Health Investment Standard in 2022/23 when taking into account spend by their predecessor CCGs in Q1, and ICBs were required to spend greater than or equal to the 2022/23 target spend number provided by NHS England.
As the Accountable Officer of NHS Nottingham and Nottinghamshire Integrated Care Board, I am responsible for the preparation of the Mental Health Investment Standard Compliance Statement (the “Statement”) for the year ended 31 March 2023 and for the financial information that forms the basis of the calculation on which the Statement is derived. This includes the design, implementation and maintenance of internal controls relevant to the preparation of the Statement to ensure that mental health expenditure is correctly classified and included in the calculations, and that the Statement is free from material misstatement, whether due to fraud or error.
To the best of my knowledge and belief I have properly discharged my responsibilities with regard to reporting against the Mental Health Investment Standard.
I consider that NHS Nottingham and Nottinghamshire ICB complied with the requirements of the Mental Health Investment Standard for 2022/23, incorporating spend by its predecessor CCGs in Quarter 1 of that year. The 2022/23 target spend was £190,665k and actual spend was £191,070k.
Amanda Sullivan
Accountable Officer
NHS Nottingham and Nottinghamshire Integrated Care Board (the successor body of Nottingham and Nottinghamshire Clinical Commissioning Group and Bassetlaw Clinical Commissioning Group)
Health Inequalities Public Statement
Counter Fraud Statement
As Chief Executive of NHS Nottingham and Nottinghamshire ICB, I am pleased to set out our commitment to remaining transparent, ethical and accountable in all that we do. In line with our overall mission to commission safe, high-quality care for patients and communities, we also recognise our responsibility to maintain the highest standards of integrity, including preventing and detecting fraud.
On 1 September 2025, a new fraud offence came into force. This is a corporate offence of ‘failure to prevent fraud’, which is part of the Economic Crime and Corporate Transparency Act 2023.
Under the failure to prevent fraud offence, organisations may be held criminally liable when a person associated with the organisation (for example an employee, agent or subsidiary) commits a specified fraud offence for the benefit of the organisation, and the organisation did not have reasonable procedures in place to prevent that fraud.
In that context, I confirm that NHS Nottingham and Nottinghamshire ICB has in place, and will maintain, procedures which we believe to be reasonable and proportionate in preventing fraud, consistent with the guidance issued by government. Specifically:
- Leadership and culture
We are committed to fostering a culture of honesty and transparency across the ICB. I personally endorse the principle that any suspected fraudulent or dishonest behaviour should be reported, investigated and addressed appropriately. - Risk assessment
We undertake regular assessments of the fraud risk profile facing the ICB, considering where and how fraudulent activity might arise within our operations, including the supply chain, agency arrangements and other partnerships. These assessments are reviewed and updated periodically. - Prevention procedures
We have implemented proportionate, risk-based procedures designed to prevent fraud. These include, but are not limited to, due diligence checks, financial controls, procurement oversight, contract monitoring, segregation of duties, clear scheme of delegations, and a whistle-blowing mechanism. Where appropriate, we provide fraud-awareness training to our staff, contractors and partners. - Communication and training
We communicate clearly to all staff and partners that fraud is unacceptable and that we expect conduct in line with the ICB’s values and standards of behaviour. We provide guidance, policies and training to support staff in identifying and reporting concerns. - Monitoring, review and continuous improvement
We monitor our procedures and controls to ensure they remain effective and relevant. Where weaknesses or control gaps are identified, we act promptly to remediate them. We review our policy and governance framework to ensure alignment with evolving risks and external guidance. - Whistle-blowing and speaking up
We have in place mechanisms for staff, contractors, agency workers and others to raise concerns without fear of reprisal. We encourage openness and will treat as a priority any reports suggesting potential fraud or misconduct, investigating them thoroughly and impartially. - Governance and accountability
The ICB’s Board has established an Audit Committee that receives assurance on fraud risk, prevention activity and control effectiveness, with regular reporting between the Committee and the Board. I, as Chief Executive, take ultimate responsibility for the arrangements and for embedding the anti-fraud culture within the organisation.
I believe the procedures set out above reflect our commitment to acting ethically, lawfully and using public funds in the best interests of patients, staff, and the public we serve. We will continue to review and refine our approach to ensure that we remain vigilant and compliant with the requirements of the Act and the associated guidance.
This statement has been approved by the Board of NHS Nottingham and Nottinghamshire ICB.
Amanda Sullivan
Reporting concerns
If you have any concerns or suspicions regarding bribery, corruption, or fraud, please contact: 360assurance.counterfraud@nhs.net
Or alternatively please contact:
NHS Fraud and Corruption Reporting Line
Telephone – 0800 028 4060

